Article Versions Notes

Hessheimer AJ, Vengohechea J, Martínez de la Maza L, Muñoz J, Vendrell M, Sanahuja JM, Torroella A, Adel Al Shwely F, Riquelme F, Muñoz C, et al. Somatostatin Therapy Improves Stellate Cell Activation and Early Fibrogenesis in a Preclinical Model of Extended Major Hepatectomy. Cancers. 2021; 13(16):3989. https://doi.org/10.3390/cancers13163989

Hessheimer, Amelia J., Jordi Vengohechea, Lilia Martínez de la Maza, Javier Muñoz, Marina Vendrell, Josep Martí Sanahuja, Alba Torroella, Farah Adel Al Shwely, Francisco Riquelme, César Muñoz, and et al. 2021. "Somatostatin Therapy Improves Stellate Cell Activation and Early Fibrogenesis in a Preclinical Model of Extended Major Hepatectomy" Cancers 13, no. 16: 3989. https://doi.org/10.3390/cancers13163989

Hessheimer, A. J., Vengohechea, J., Martínez de la Maza, L., Muñoz, J., Vendrell, M., Sanahuja, J. M., Torroella, A., Adel Al Shwely, F., Riquelme, F., Muñoz, C., García, R., Taurá, P., & Fondevila, C. (2021). Somatostatin Therapy Improves Stellate Cell Activation and Early Fibrogenesis in a Preclinical Model of Extended Major Hepatectomy. Cancers, 13(16), 3989. https://doi.org/10.3390/cancers13163989